Search results for "mortality"

showing 10 items of 1406 documents

Changes in lung-cancer mortality trends in Spain

2001

Several changes in smoking patterns over the past decades in Spain can be expected to result in a shift in lung-cancer mortality rates. We examined time trends in lung-cancer mortality from 1973-1997 using a log-linear Poisson age-period-cohort model. The standardized lung-cancer mortality rate for men almost doubled, from 31.4 per 100,000 in 1973 to 58.6 in 1997, with an average annual increase of 2.7%. Mortality increased for male generations born until 1952 as a consequence of the increasing cigarette smoking in successive birth cohorts. However, the slight downward trend observed for the 2 youngest generations suggests a more favorable outcome of the lung-cancer epidemic among Spanish m…

Cancer Researchmedicine.medical_specialtybusiness.industryMortality ratePublic healthmedicine.diseaseTobacco smokeSurgeryOncologyCohort effectEpidemiologyCompensation law of mortalityMedicinebusinessLung cancerCohort studyDemographyInternational Journal of Cancer
researchProduct

Predictions of cancer mortality in Europe in 2021: room for hope in the shadow of COVID-19?

2021

Cancer mortality2019-20 coronavirus outbreakCoronavirus disease 2019 (COVID-19)business.industrySARS-CoV-2Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)COVID-19HematologyVirologyEuropeHopeOncologyNeoplasmsMedicineHumansbusinessShadow (psychology)Annals of oncology : official journal of the European Society for Medical Oncology
researchProduct

Quantification of exposure to dioxins and furans in a cohort of workers of a herbicide producing plant in hamburg, FRG

1992

Abstract To assess the exposure to PCDD/Fs of a cohort of 1583 workers of a herbicide producing plant in Hamburg, FRG, investigated for cancer mortality, measurements of PCDD/Fs in fat tissue (n=48) or blood (n=64) were analyzed according to work histories in a subgroup of n=112 male workers. In a multiple regression analysis the time of work in the production of 2,4,5-T and 2,4,5-TCP, for the latter especially before 1957, correlated well with the levels of 2378-tetrachlorodibenzo-p-dioxin (TCDD). For most of the higher chlorinated isomers time of work in the thermic decomposition showed the strongest effect. The results confirm that the developed indicators are good proxis for exposure to…

Cancer mortalityEnvironmental Engineeringbusiness.industryHealth Toxicology and MutagenesisPublic Health Environmental and Occupational HealthEnvironmental engineeringRegression analysisGeneral MedicineGeneral ChemistryPollutionMale workersEnvironmental healthCohortEnvironmental ChemistryMedicinebusinessChemosphere
researchProduct

Tricuspid valve repair with the Cardioband system: two-year outcomes of the multicentre, prospective TRI-REPAIR study

2021

AIMS: Tricuspid regurgitation (TR) is associated with high morbidity and mortality rates with limited treatment options. We report one- and two-year outcomes of the Cardioband tricuspid valve reconstruction system in the treatment of ≥moderate functional TR in the TRI-REPAIR study. METHODS AND RESULTS: Thirty patients were enrolled in this single-arm, multicentre, prospective study. Patients were evaluated as having ≥moderate, symptomatic functional TR and deemed inoperable due to unacceptable surgical risk. Clinical, functional, and echocardiographic data were prospectively collected up to two years (mean duration 604±227 days). At baseline, 83% were in NYHA Class III-IV, and the mean LVEF…

Cardiac Catheterizationmedicine.medical_specialtyTime Factors030204 cardiovascular system & hematologySeverity of Illness Index03 medical and health sciences0302 clinical medicineQuality of lifeClinical ResearchInternal medicineHumansMedicineIn patientProspective Studies030212 general & internal medicineTRICUSPID VALVE REPAIRProspective cohort studyRetrospective StudiesHeart Valve Prosthesis ImplantationEjection fractionTricuspid valvebusiness.industryWalk distanceMortality rateTricuspid Valve InsufficiencyTreatment Outcomemedicine.anatomical_structureCardiologyTricuspid ValveCardiology and Cardiovascular MedicinebusinessEuroIntervention
researchProduct

Destination Therapy with Left Ventricular Assist Devices in Non-transplant Centres: The Time is Right

2020

For almost half a century, cardiac transplant has been the only long-term treatment for patients with end-stage heart failure. Implantable left ventricular assist devices (LVADs) have emerged as a new treatment option for advanced heart failure as destination therapy for patients either too old or not suitable for transplant. A meta-analysis presenting head-to-head comparisons of cardiac transplant versus LVAD as destination therapy (LVAD-DT) found no difference in 1-year mortality rates between LVAD-DT and cardiac transplant (OR 1.49; 95% CI [0.48–4.66]; I2=82.8%). Moreover, a recent subanalysis from the Interagency Registry for Mechanically Assisted Circulatory Support found similar outco…

Cardiac transplantlcsh:Diseases of the circulatory (Cardiovascular) systemmedicine.medical_specialtyCardiomyopathy030204 cardiovascular system & hematologyoutcomes03 medical and health sciences0302 clinical medicineInternal medicineleft ventricular assist deviceDiseases of the circulatory (Cardiovascular) systemMedicine030212 general & internal medicineMyocardial infarctionStrokeHeart Failurebusiness.industryMortality rateAtrial fibrillationmedicine.diseaseequipment and supplieslcsh:RC666-701RC666-701Heart failureCirculatory systemCardiologydestination therapyCardiology and Cardiovascular MedicinebusinessDestination therapyEuropean Cardiology Review
researchProduct

Relationships between diuretic related hyperuricemia and cardiovascular events: data from the URRAH (URic acid Right for heArt Health) study.

2021

Objective Although the relationship between hyperuricemia and cardiovascular events has been extensively examined, data on the role of diuretic-related hyperuricemia are still scanty. The present study was designed to collect information on the relationship between diuretic-related hyperuricemia and cardiovascular events. Methods The URic acid Right for heArt Health (URRAH) study is a nationwide, multicentre, observational cohort study involving data on individuals recruited from all the Italy territory under the patronage of the Italian Society of Hypertension with an average follow-up period of 122.3 ± 66.9 months. Patients were classified into four groups according to the diuretic use (y…

Cardiovascular eventMalemedicine.medical_specialtySettore MED/09 - Medicina InternaPhysiologymedicine.medical_treatmentdiureticRenal functionHyperuricemiaCardiovascular eventcardiovascular events; cardiovascular mortality; diuretic; uric acid030204 cardiovascular system & hematology03 medical and health scienceschemistry.chemical_compoundcardiovascular events0302 clinical medicineuric acidRisk Factorscardiovascular mortalityInternal medicineInternal MedicinemedicineHumans030212 general & internal medicineHyperuricemiaDiureticsHeart healthUric acid cardiovascular events diuretics epidemiologycardiovascular events cardiovascular mortality diuretic uric acidbusiness.industrySerum uric acidMiddle Agedmedicine.diseasechemistryHypertensionUric acidDiureticCardiology and Cardiovascular MedicinebusinessCohort study
researchProduct

Hospital and outpatient models for Hematopoietic Stem Cell Transplantation: A systematic review of comparative studies for health outcomes, experienc…

2021

The number of Hematopoietic Stem Cell Transplantations has risen in the past 20 years. The practice of outpatient Hematopoietic Stem Cell Transplantation programs is increasing in an attempt to improve the quality of patient care and reduce the demand for hospital admission. A systematic review of 29 comparative studies between in-hospital and outpatient treatment of Hematopoietic Stem Cell Transplantation, with no restriction by outpatient regime was conducted. This study aims to analyse the current evidence on the effects of the outpatient model on patient-centred outcomes, comparing both in-hospital and outpatient models for autologous and allogeneic HSCT using the Triple Aim framework: …

Cell Transplantationmedicine.medical_treatmentFeversHematopoietic stem cell transplantationHealth careOutpatientsMedicine and Health SciencesBlood and Lymphatic System ProceduresOutpatient clinicMultidisciplinaryMortality rateQRHematopoietic Stem Cell TransplantationHematopoietic stem cellResearch AssessmentHospitalsSurvival Ratemedicine.anatomical_structureSystematic reviewModels EconomicCosts and Cost AnalysisMedicineResearch Articlemedicine.medical_specialtyPatientsSystematic ReviewsDeath RatesScienceSurgical and Invasive Medical ProceduresHealth outcomesResearch and Analysis MethodsTransplantation AutologousDisease-Free SurvivalQuality of life (healthcare)Signs and SymptomsPopulation MetricsmedicineHumansTransplantation HomologousIntensive care medicineOutpatient ClinicsTransplantationInpatientsPopulation Biologybusiness.industryBiology and Life SciencesLength of StayHealth CareHealth Care FacilitiesQuality of LifeClinical MedicinebusinessStem Cell TransplantationPloS one
researchProduct

Risk Factors and Molecular Features Associated with Bladder Cancer Development

2017

Bladder cancer remains a global epidemiologic problem, with a strong male predominance and association with tobacco smoking. However, several other risk factors have also been associated with development of this disease, which is characterized by alterations in multiple molecular pathways. Development of the more prevalent, less aggressive, recurrent, noninvasive tumors is characterized by constitutive activation of the Ras–MAPK pathway. The less common but more aggressive invasive tumors, which have a higher mortality rate, are characterized by alterations in the p53 and retinoblastoma pathways. Alterations in pathways involved in cell-cycle regulation, apoptosis, cell signaling, angiogene…

Cell signalingBladder cancerRetinoblastomabusiness.industryAngiogenesisMortality rate030232 urology & nephrologyDiseaseCell cyclemedicine.diseaseBioinformatics03 medical and health sciences0302 clinical medicineApoptosis030220 oncology & carcinogenesismedicinebusiness
researchProduct

Socioeconomic factors and cervical cancer mortality in Spain during the period 1989?1997

2002

A study was made of cervical cancer (CC) mortality trends in Spain during the period 1989–1997 at National, Autonomous Community and Provincial levels, in relation to different socioeconomic factors. Data were obtained from the Spanish National Institute of Statistics (Instituto Nacional de Estadistica, INE). The crude mortality rates were age-adjusted using the indirect method and Gross Domestic Product (GDP) as socioeconomic status (SES) indicator. National CC age-adjusted mortality rates have increasing slightly, varying from 3.09 deaths/100,000 women in 1989 to 3.42 in 1996. The highest age-adjusted mortality rates corresponded to Seville, Palencia and Orense, with 4.13, 4.06 and 3.98 c…

Cervical cancerbusiness.industryMortality rateUterine Cervical NeoplasmsObstetrics and GynecologyGeneral Medicinemedicine.diseaseGross domestic productSocioeconomic FactorsRisk FactorsSpainRelative riskmedicineHumansFemaleHuman papillomavirusParity (mathematics)Mortality trendsbusinessSocioeconomic statusDemographyDemographyArchives of Gynecology and Obstetrics
researchProduct

2017

Summary Background The UN's Sustainable Development Goals (SDGs) are grounded in the global ambition of "leaving no one behind". Understanding today's gains and gaps for the health-related SDGs is essential for decision makers as they aim to improve the health of populations. As part of the Global Burden of Diseases, Injuries, and Risk Factors Study 2016 (GBD 2016), we measured 37 of the 50 health-related SDG indicators over the period 1990–2016 for 188 countries, and then on the basis of these past trends, we projected indicators to 2030. Methods We used standardised GBD 2016 methods to measure 37 health-related indicators from 1990 to 2016, an increase of four indicators since GBD 2015. W…

Child abuseEconomic growthbusiness.industry1. No povertyGeneral Medicine030204 cardiovascular system & hematologyMillennium Development GoalsInfant mortality3. Good health03 medical and health sciences0302 clinical medicineScale (social sciences)Global healthMedicine030212 general & internal medicineIndicator valueSex offense10. No inequalitybusinessHealth policyThe Lancet
researchProduct